Treatment-resistant depressionA systematic review of systematic reviews

  1. Pérez Wehbe, Alia Inés
  2. Perestelo Pérez, Lilisbeth
  3. Bethencourt Pérez, Juan Manuel
  4. Cuéllar Pompa, Leticia
  5. Peñate Castro, Wenceslao
Revue:
International journal of clinical and health psychology

ISSN: 1697-2600

Année de publication: 2014

Volumen: 14

Número: 2

Pages: 145-153

Type: Article

DOI: 10.1016/S1697-2600(14)70048-1 DIALNET GOOGLE SCHOLAR

D'autres publications dans: International journal of clinical and health psychology

Objetivos de desarrollo sostenible

Information sur le financement

This work was supported by a grant from the Canary Islands Foundation for Health Research (FUNCIS; Exp. 51/09).

Références bibliographiques

  • Aguilera, A., Garza, M. J., & Muñoz, R. F. (2010). Group cognitivebehavioural therapy for depression in Spanish: culture-sensitive manualised treatment in practice. Journal of Clinical Psychology, 66, 857-867.
  • Álvarez, E., Baca, B. E., Bousoño, M., Eguiluz, I., Martín, M., Roca, M., & Urretavizcaya, M. (2008). Depresiones resistentes. Actas Españolas de Psiquiatría, 36, 35-43.
  • American Psychiatric Association, APA (2000). Diagnostic and Statistical Manual of Mental Disorders IV-TR (4th ed. rev.). Washington, DC: APA.
  • Anderson, I. M., Nutt, D. J., & Deakin, J. F. (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. Journal of Psychopharmacology, 14, 3-20.
  • *Barowsky, J., & Schwartz, T. L. (2006). An evidence-based approach to augmentation and combination strategies for treatment-resistant depression. Psychiatry, 3, 42-61.
  • *Bauer, M., Tharmanathan, P., Volz, H. P., Moeller, H. J., & Freemantle, N. (2009). The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: A meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 259, 172-185.
  • *Berlim, M. T., & Turecki, G. (2007). Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods. Canadian Journal of Psychiatry, 52, 46-54.
  • Bretlau, L. G., Lunde, M., Lindberg, L., Unden, M., Dissing, S., & Bech, P. (2008). rTMS in combination with escitalopram in patients with treatment-resistant major depression: a doubleblind, randomised, sham-controlled trial. Pharmacopsychiatry, 41, 41-47.
  • *Bschor, J., & Baethge, C. (2010). No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy. Acta Psychiatrica Scandinavica, 121, 174-179.
  • *Bschor, T., & Bauer, M. (2006). Efficacy and mechanisms of action of Lithium augmentation in refractory major depression. Current Pharmaceutical Design, 2, 381-386.
  • Catafau, A. M., Perez, V., Gironell, A., Martin, J. C., Kulisevsky, J., Estorch, I., & Alvarez, E. (2001). SPECT mapping of cerebral activity changes induced by rTMS in depressed patients. A pilot study. Psychiatry Research: Neuroimaging, 106, 151-160.
  • *Daban, C., Martinez-Aran, A., Cruz, N., & Vieta, E. (2008). Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review. Journal of Affective Disorders, 110, 9-24.
  • Davidson, J. R. (2010). Major depressive disorder treatment guidelines in America and Europe. Journal of Clinical Psychiatry, 71, 4-11.
  • *Dodd, S., Horgan, D. Malhi, G. S., & Berk, M. (2005). Combine or not to combine? A literature review of antidepressant combination therapy. Journal of Affective Disorders, 89, 45-56.
  • Eby, G. A., & Eby, K. L. (2010). Magnesium for treatment-resistant depression: a review and hypothesis. Medical Hypotheses, 74, 649-660.
  • *Fekadu, A., Wooderson, S. C., Markopoulo, K., Donaldson, C., Papadopoulos, A., & Cleare, A. J. (2009). What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. Journal of Affective Disorders, 116, 4-11.
  • Fernández-Ríos, L., & Buela-Casal, G. (2009). Standards for the preparation and writing of Psychology review articles. International Journal of Clinical and Health Psychology, 9, 329-344.
  • Gabriel, A. (2006). Lamotrigine adjunctive treatment in resistant unipolar depression. Depression and Anxiety, 23, 485-488.
  • Geddes, J. R., Carney, S. M., Davies, C., Fukurawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 22, 653-661.
  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
  • Jenkins, E., & Goldner, E. M. (2012). Approaches to understanding and addressing treatment-resistant depression: A scoping review. Depression Research and Treatment, 2 [accessed 31 Jan, 2013]. Available from: http://www.hindawi.com/journals/drt/2012/469680/
  • Kaltenthaler, E., Brazier, J., de Nigris, E., Tumur, I., Ferriter, M., Beverley, C., Parry, G., Rooney, G., & Sutcliffe, P. (2006). Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technology Assessment, 10, 11-14.
  • Kennedy, S. H., & Giacobbe, P. (2007). Treatment resistant depression - Advances in somatic therapies. Annals of Clinical Psychiatry, 19, 279-287.
  • *Lam, R. W., Chan, P., Wilkins-Ho, M., & Yatham, L. N. (2008). Repetitive transcranial magnetic stimulation for treatmentresistant depression: A systematic review and metaanalysis. Canadian Journal of Psychiatry, 53, 621-631.
  • *Lam, R. W., Wan, D. D., Cohen, N. L., & Kennedy, S. H. (2002). Combining antidepressants for treatment-resistant depression: A review. Journal of Clinical Psychiatry, 63, 685-693.
  • Mahmoud, R. A., Pandina, G. J., Turkoz, I., Kosik-Gonzalez, C., Canuso, C. M., Kujawa, M. J., & Gharabawi-Garibaldi, G. M. (2007). Risperidone for treatment-refractory major depressive disorder: a randomized trial. Annual of Internal Medicine, 147, 593-562.
  • McKenna, M. T., Michaud, C. M., Murray, C. J., & Marks, J. S. (2005). Assessing the burden of disease in the United States using disability-adjusted life years. American Journal of Preventive Medicine, 28, 415-423.
  • *McPherson, S., Cairns, P., Carlyle, J., Shapiro, D. A., Richardson, P., & Taylor, D. (2005). The effectiveness of psychological treatments for treatment-resistant depression: A systematic review. Acta Psychiatrica Scandinavica, 111, 331-340.
  • Merry, S., McDowell, H., Hetrick, S., Bir, J., & Muller, N. (2004). Psychological and/or educational interventions for the prevention of depression in children and adolescents. Cochrane Database Systematic Reviews, 1, CD003380 [accessed 17 Mar 2013]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003380.pub2
  • Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
  • National Institute for Health and Clinical Excellence, NICE (2009). NICE clinical guideline 90. Depression: The treatment and management of depression in adults (update) [accessed 28 Feb 2013]. Available from: http://publications.nice.org.uk/depression-in-adults-cg90
  • Nierenberg, A. A., Papakostas, G. I., Petersen, T., Montoya, H. D., Worthington, J. J., Tedlow, J., Alpert, J. E., & Fava, M. (2003). Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. Journal of Clinical Psychopharmacology, 23, 92-95.
  • O'Reardon, J. P., Thase, M. E., & Papakostas, G. I. (2009). Pharmacological and therapeutic strategies in treatment resistant depression. Introduction and clinical presentations. CNS Spectrums, 14, 4-6.
  • Oxman, A. D., Cook, D. J., & Guyatt, G. H. (1994). User's guides to the medical literature. VI. How to use an overview. Journal of the American Medical Association, 272, 1367-1371.
  • Padberg, F., & George, M. S. (2009). Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Expert Neurology, 219, 2-13.
  • Parker, G., Blanch, B., & Crawford, J. (2010). Does gender influence response to differing psychotherapies by those with unipolar depression? Journal of Affective Disorders, 130, 17-20.
  • Perestelo-Pérez, L. (2013). Standards on how to develop and report systematic reviews in Psychology and Health. International Journal of Clinical and Health Psychology, 13, 49-57.
  • Perestelo Pérez, L., García Pérez, L., Peñate Castro, W., Pérez Ramos, J., Rivero Santana, A., De las Cuevas Castresana, C., & González Lorenzo, M. (2010). Fármacos antidepresivos y tratamientos psicológicos para los trastornos depresivos: Una revisión y evaluación económica. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Servicio de Evaluación del Servicio Canario de la Salud. Informes de Evaluación de Tecnologías Sanitarias: SESCS No 2007/16. Madrid: Ministerio de Ciencia e Innovación.
  • Rocha, F. L., & Hara, C. (2003). Lamotrigine augmentation in unipolar depression. International Clinical Psychopharmacology, 18, 97-99.
  • Ruelaz, A. R. (2006). Treatment-resistant depression: Strategies for management. Psychiatric Times, 23, 122-129.
  • *Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P., & Schene, A. H. (2012). Staging methods for treatment resistant depression. A systematic review. Journal of Affective Disorders, 137, 35-45.
  • *Sarnecki, T., & Temel, Y. (2011). Deep brain stimulation for treatment-resistant depression: A review. Open Neurosurgery Journal, 4, 22-28.
  • Schlaepfer, T. E., George, M. S., & Mayberg, H. (2009). WFSBP guidelines on brain stimulation treatments in psychiatry. Journal of Biological Psychiatry, 26, 1-17.
  • Shelton, R. C., Osuntokun, O., Heinloth, A. N., & Corya, S. A. (2010). Therapeutic options for treatment-resistant depression. CNS Drugs, 24, 131-161.
  • Sobis, J., Jarzab, M., Hese, R. T., Sieron, A., Zyss, T., Gorczyca, P., Pudlo, R., & Matysiakiewicz, J. (2010). Therapeutic efficacy assessment of weak variable magnetic fields with low value of induction in patients with drug-resistant depression. Journal of Affective Disorders, 123, 321-326.
  • *Stimpson, N., Agrawal, N., & Lewis, G. (2002). Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. British Journal of Psychiatry, 181, 284-294.
  • Thase, M. E., & Rush, A. J. (1997). When at first you don't succeed: Sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry, 58, 23-29.
  • *Thomas, S. P., Nandhra, H. S., & Jayaraman, A. (2010). Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). Journal of Mental Health, 19, 168-175.
  • Triggs, W. J., Ricciuti, N., Ward, H. E., Cheng, J., Bowers, D., Goodman, W. K., Kluger, B. M., & Nadeau, S. E. (2010). Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Psychiatry Research, 178, 467-474.
  • *Trivedi, R. B., Nieuwsma, J. A., & Williams, J. W. (2011). Examination of the utility of psychotherapy for patients with treatment resistant depression: A systematic review. Journal of General Internal Medicine, 26, 643-650.
  • Vigo, D. V., & Baldessarini, R. J. (2009). Anticonvulsants in the treatment of major depressive disorder: an overview. Harvard Review in Psychiatry, 17, 231-241.
  • World Health Organization, WHO (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: Author.
  • World Health Organization, WHO (2005). WHO global report: Preventing chronic diseases: A vital investment. Geneva: World Health Organization [accessed 4 Apr 2013]. Available from: http://www.who.int/chp/chronic_disease_report/en/